Ex-Monsanto CEO Defends Roundup, Concedes Study Limits

Law360, San Francisco (March 25, 2019, 7:38 PM EDT) -- In videotaped testimony played at a Roundup cancer trial on Monday, Monsanto's former CEO conceded the company never conducted epidemiological cancer studies on the weedkiller, while saying the agri-giant based its practices on "sound science." 

During his direct examination, Hugh Grant, who served as Monsanto’s CEO for 15 years before Bayer AG acquired the company in June for $63 billion, said repeatedly that Monsanto is a "science-based company" and regulators around the world have "vouched" for the safety of its Roundup products for decades.

However, Grant also said he has “no idea” how many studies have been done on the safety...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS